88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma CHENGDU, China , July 15, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed (HKEX: 02142) today ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NATIONAL UNIVERSITY HOSPITAL TO EXPAND WEARABLE TECHNOLOGY FOR PATIENT MONITORING FOLLOWING SUCCESSFUL PILOT Continuous smartwatch monitoring shown to safely support post-surgical care, reducing disruptions for patients and easing nursing time for direct patient care ... 2026-07-15T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio Executive Chair Mark Crotty to continue guiding long-term strategic direction ... 2026-07-15T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million TAIPEI and SAN DIEGO , July 15, 2026 /PRNewswire/ -- GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") with the existing shareholders of Taiwan-listed ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis HANGZHOU, China and SHANGHAI and BOSTON , July 15, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the superiority of replacing ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process NEWARK, Del. , July 15, 2026 /PRNewswire/ -- Recently, ACROBiosystems has officially received the "Material Suitability Confirmation for Regenerative Medicine Products" (Certificate No.: 藥機審長發第47號) ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction BGE-102, a potent, structurally novel, orally available, brain-penetrant small molecule NLRP3 inhibitor developed from a hit identified via HitGen's DEL technology platform, has advanced into a Phase 2 ... 2026-07-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Rayence Launches 'SHINE,' a Next-Generation X-ray Image Processing Technology for Low Dose Imaging - Development of next-generation denoising image processing technology 'SHINE' completed; full-scale commercialization now underway ... 2026-07-14T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved